Home / Equities / The three steps that matter for contrarian investors in the ‘zero-sum game’

The three steps that matter for contrarian investors in the ‘zero-sum game’

Contrarian investors are adept at spotting misalignment that leads to arbitrage between real value and perceived value. But it isn't easy. "True bargains are hard to come by," says Orbis Investments' Eric Marais.
Equities

The fundamental premise of contrarian investing is that the investor is looking for someone to sell a stock for less than its intrinsic value. The problem is, it shouldn’t really happen.

For contrarian purveyors Orbis, the fact that this doesn’t happen very often is why the research that goes into investing opportunities to find value in the market is so robust.

“We look for things that have fallen out of favour for one reason or another,” Orbis investment specialist Eric Marais tells The Inside Adviser.

  • “The reason for that is pretty simple; at the end of the day, public equity investing is a zero-sum game and if we want something that’s worth more than what we pay for it, somebody else has to sell it to us for less than what it’s worth,” he explains. “But true bargains are hard to come by.”

    There are occasions when it does happen, however. “The most common reason why that might happen is because people have been pushed and there’s been a run of bad news, which leads to people getting a bit overly pessimistic,” he says. “Those are the sorts of situations we look for.”

    But finding a misalignment that leads to arbitrage between real value and perceived value takes equal measures of knowledge and nous, plus a good dose of thorough research. According to Marais, that research element generally involves three distinct phases that take place over approximately three months.

    “Idea generation tends to be quite flexible, but after that we have quite a rigid investment process, he explains. “In phase one we’re doing quite high level work, maybe just a day, just to solidify whether we have something worth exploring. Phase two might be a week or two, and involves doing more desktop research on the idea and fleshing it out more. And then phase three can be really long, depending on the idea; it can be anything from an extra few weeks up to an additional two or three months.”

    In that crucial third phase, he says, Orbis is doing the work of stress testing the investment idea.

    “And that often involves doing some primary research like running surveys, scraping websites, all the things that can take time,” Marais continues. “We have what we call our Investment Insights Team that assists our investment analysts with doing that sort of work.”

    Ultimately, however, the investment idea will hinge on what contrarian investors look for above all else: pricing value.

    “We’re very price sensitive,” he says. “Our analysts always have a view on what they think the intrinsic value for a company is, and we’re looking for a deep discount that intrinsic value.”

    Tahn Sharpe

    Tahn is managing editor across The Inside Network's three publications.




    Print Article

    Related
    Expectations matter, and the market’s ‘big fluffy toys’ have set a historically high bar: Orbis

    Valuations at the top end of indexes are sky high, but with that comes inflated forecast earnings. For savvy investors, it may be time to rotate towards more value-oriented stocks according to Eric Marais from Orbis Investments.

    Tahn Sharpe | 22nd Apr 2024 | More
    The answer to the Magnificent Seven’s ‘really difficult investment problem’

    A huge benefit has already been realised in the price of the Magnificent Seven and it might be time to take some risk off the table instead of speculating on future fundamentals, according to Lazard.

    Staff Writer | 18th Apr 2024 | More
    Time to look ‘off the beaten path’ for growth: Franklin Templeton

    The incredible performance of the Magnificent Seven mean investors aren’t always seeing the technological growth that’s driving industries like professional services, construction and medicine.

    Staff Writer | 15th Apr 2024 | More
    Popular
  • Popular posts: